By By Chris Wack
Shares of Organigram Holdings surge 29% following a substantial investment
Organigram Holdings, a leading cannabis company, experienced a significant boost in its stock performance after BT DE Investments, a wholly owned subsidiary of BAT, made a strategic equity investment of C$124.6 million ($91.1 million). As a result, Organigram’s shares soared to $1.50. This investment comes at a time when the company was striving to expand its operations beyond Canada and fortify its financial position for sustainable growth.
Strengthening Financial Position and Expanding Business Footprint
Seeking to extend its global reach, Organigram will leverage the investment to enhance its core business operations and achieve cost-saving efficiencies, resulting in accelerated earnings growth. A major portion of the investment will be allocated to the creation of a strategic investment pool called Jupiter. Jupiter will focus on investing in emerging cannabis opportunities, enabling Organigram to leverage its industry-leading capabilities and expertise in new markets.
Promising Outlook for Organigram
The surge in investment marks an important milestone for Organigram Holdings, reversing a downward trend in its stock price that saw it reach a 52-week low of 97 cents on October 27th. With this substantial infusion of funds, the company is poised for significant growth and an enhanced competitive edge in the evolving cannabis industry.
Comments